6Schrier RW,Abraham WT.Hormones and hemodynamics in heart failure[J].N Engl J Med,1999,341(8):577-585.
7Konstam MA,Rousseau MF,Kronenberg MW,et al.Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure.SOLVD Investigators[J].Circulation,1992,86(2):431-438.
8Cohn JN,Tognoni G.A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure[J].N Engl J Med,2001,345(23):1667-1675.
9Young JB,Dunlap ME,Pfeffer MA,et al.Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction:results of the CHARM low-left ventricular ejection fraction trials[J].Circulation,2004,110(17):2618-2626.
10Pitt B,Zannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure.Randomized Aldactone Evaluation Study Investigators[J].N Engl J Med,1999,341(10):709-717.
